Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2011
03/24/2011WO2011033961A1 Phospholipase a1, gene encoding phospholipase a1, expression vector, transformant, process for production of phospholipase a1
03/24/2011WO2011033960A1 Novel micro-organism, boron scavenger, and method for scavenging boron
03/24/2011WO2011033633A1 Lactase preparation
03/24/2011WO2011033375A2 Products and methods for enhanced transgene expression and processing
03/24/2011WO2011033371A1 A method of modifying the carbohydrate content of a plant
03/24/2011WO2011033061A2 Method for the production of recombinant proteins by green microalgae
03/24/2011WO2011032934A1 Method for the enzymatic production of 3-hydroxy-s-methylbutyric acid from acetone and acetyl-coa
03/24/2011WO2011032722A1 Module-based vector useful in the assessment of antigen-specific t cell functions
03/24/2011WO2011032537A1 Inhibition of the running to seed and flowering of a sugar beet plant
03/24/2011WO2011032284A1 Steroidogenesis modified cells and methods for screening for endocrine disrupting chemicals
03/24/2011WO2011032243A1 Methods and kits for the identification of animals having a greater potential for desirable characteristics, and for the early identification of fat deposits in bovines
03/24/2011WO2011032213A1 Nucleic acid molecule encoding triterpenoid synthase
03/24/2011WO2011013130A3 Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
03/24/2011WO2011005786A3 Compositions and methods for enhancing production of a biological product
03/24/2011WO2010140388A3 Gene for increasing plant weight and method for using the same
03/24/2011WO2010135728A3 Extracellular plant ferredoxin-like protein and uses thereof
03/24/2011WO2010129937A3 Methods for detecting genetic variations in dna samples
03/24/2011WO2010128524A3 Combined measles-malaria vaccine
03/24/2011WO2010127290A3 Improved isoprene hydrocarbon production using genetically engineered cyanobacteria
03/24/2011WO2010127209A3 Compositions and methods for therapy of macular degeneration
03/24/2011WO2010124000A3 Modified cipa gene from clostridium thermocellum for enhanced genetic stability
03/24/2011WO2010120803A3 Methods and compositions for detection of small rnas
03/24/2011WO2010118205A3 Production of an intact virus in a mammalian (non-host) cell system using a secondary non-host viral construct
03/24/2011WO2010118093A3 Screening for environmental dnas encoding enzymes for synthesizing terpenoid-based therapeutic compounds using genetically modified e. coli strains
03/24/2011WO2010115210A3 Mouse models
03/24/2011WO2010111522A3 Mesenchymal stem cells producing inhibitory rna for disease modification
03/24/2011WO2010111422A3 Induced pluripotent stem cell generation using two factors and p53 inactivation
03/24/2011WO2010093860A3 Isolation of factors that associate directly or indirectly with chromatin
03/24/2011WO2010027484A9 Engineering polymerases and reaction conditions for modified incorporation properties
03/24/2011WO2010017544A3 Long - acting dna dendrimers as vectors for the delivery of sirna
03/24/2011US20110072541 Marker free transgenic plants engineering the chloroplast genome without the use of antibiotic selection
03/24/2011US20110072537 Genetically modified plants having desirable traits
03/24/2011US20110072536 Hybrid artichoke variety nun 4021 ar
03/24/2011US20110072535 Soybean Cultivar S080046
03/24/2011US20110072534 Rice Cultivar Templeton
03/24/2011US20110072527 I-crei meganuclease variants with modified specificity, method of preparation and uses thereof
03/24/2011US20110072526 Process for producing exogenous protein in the milk of transgenic mammals and a process for purifying proteins therefrom
03/24/2011US20110071284 Novel b-type gene from oil palm
03/24/2011US20110071283 Haemocoagulase
03/24/2011US20110071278 Antibodies that recognize cutting edge within the tgf- beta activation controlling region
03/24/2011US20110071273 Chimeric antigen-specific t cell-activating polypeptides
03/24/2011US20110071214 Methods and compositions for the treatment of cancer
03/24/2011US20110071213 Card-domain containing polypeptides, encoding nucleic acids, and methods of use
03/24/2011US20110071212 P185neu-encoding dna and therapeutical uses thereof
03/24/2011US20110071211 MicroRNA (miRNA) And Downstream Targets For Diagnostic And Therapeutic Purposes
03/24/2011US20110071209 RNAi Modulation of the RHO-A Gene and Uses Thereof
03/24/2011US20110071087 Polypeptides having modulatory effects on cells
03/24/2011US20110071073 Detection of mutations in a gene associated with resistance to viral infection, OAS1
03/24/2011US20110071068 Subtilases
03/24/2011US20110071049 Methods and compositions for translational profiling and molecular phenotyping
03/24/2011US20110071047 Promoter detection and analysis
03/24/2011US20110071046 Matrix screening method
03/24/2011US20110071029 Wheat plants having increased resistance to imidazolinone herbicides
03/24/2011US20110071028 Actin regulatory elements for use in plants
03/24/2011US20110071024 Rice Cultivar CL 142-AR
03/24/2011US20110070656 Fluorescent Proteins
03/24/2011US20110070653 INHIBITOR OF HISTONE ACETYLTRANSFERASE, ESPECIALLY p300
03/24/2011US20110070652 Phage microarray profiling of the humoral response to disease
03/24/2011US20110070651 Recombinant viral vector for gene transfer into lymphoid cells
03/24/2011US20110070650 Method of Enhancing Homologous Recombination of Somatic Cells and Method of Acquiring Specific Antibody
03/24/2011US20110070649 Method for manufacturing glycoproteins having human-type glycosylation
03/24/2011US20110070640 Optimized high yield synthetic plasmids
03/24/2011US20110070638 Apparatus and method for preparative scale purification of nucleic acids
03/24/2011US20110070629 Method for micropropagation of monocots based on sustained totipotent cell cultures
03/24/2011US20110070626 Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
03/24/2011US20110070625 Novel fluorescent proteins and methods for using same
03/24/2011US20110070623 Self-inactivating helper adenoviruses for the production of high-capactiy recombinant adenoviruses
03/24/2011US20110070615 Compositions and Methods Relating to Anti-IGF-1 Receptor Antibodies
03/24/2011US20110070609 Production of Foreign Nucleic Acids and Polypeptides in Sprout Systems
03/24/2011US20110070584 Methods and compositions for diagnosing and monitoring autoimmune and chronic inflammatory diseases
03/24/2011US20110070579 Polyketide synthase-nonribosomal peptide synthetase gene
03/24/2011US20110070352 Wheat with altered branching enzyme activity and starch and starch containing products derived therefrom
03/24/2011US20110070265 Engineered pertactin variants for vaccine use
03/24/2011US20110070264 Rabies virus vector systems and compositions and methods thereof
03/24/2011US20110070262 Viral Vectors and Their Use in Therapeutic Methods
03/24/2011US20110070256 Vaccine Antigens from Piscirickettsia Salmonis
03/24/2011US20110070254 Mutations in the influenza a virus ns1 gene and use thereof
03/24/2011US20110070253 Tumour-associated peptides binding to mhc molecules
03/24/2011US20110070249 IMMUNIZING COMPOSITION AND METHOD FOR INDUCING AN IMMUNE RESPONSE AGAINST THE Beta-SECRETASE CLEAVAGE SITE OF AMYLOID PRECURSOR PROTEIN
03/24/2011US20110070246 Antibodies Against CDCP1 for the Treatment of Cancer
03/24/2011US20110070245 Imp-1 oncogene as a therapeutic target and prognostic indicator for lung cancer
03/24/2011US20110070243 Compositions and methods for the treatment of tumor of hematopoietic
03/24/2011US20110070234 Np1 activity regulating elements useful for the production of drugs for the treatment or prevention of human neurodegenerative diseases, resulting drugs and use thereof
03/24/2011US20110070203 Mesendoderm and mesoderm cell populations
03/24/2011US20110070195 Uses of spatial configuration to modulate protein function
03/24/2011US20110070162 Rna interference mediating small rna molecules
03/24/2011DE112008002525T5 Pflanzen mit erhöhten Ertragsmerkmalen und Verfahren zu ihrer Herstellung Plants having increased yield-related traits and processes for their preparation
03/24/2011CA2780512A1 Isolated australian coral reef fluorescent proteins and cell-based kinase or phosphatase platforms for cancer drug development
03/24/2011CA2774640A1 Virus like particles comprising target proteins fused to plant viral coat proteins
03/24/2011CA2774475A1 Lassa virus-like particles and methods of production thereof
03/24/2011CA2774470A1 Products and methods for enhanced transgene expression and processing
03/24/2011CA2774456A1 Cloning and exploitation of a functional r-gene from solanum chacoense
03/24/2011CA2774408A1 Glycerol-3-phosphate acyltransferase
03/24/2011CA2774391A1 A method of modifying the carbohydrate content of a plant
03/24/2011CA2774349A1 Recurrent gene fusions in prostate cancer
03/24/2011CA2774342A1 Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
03/24/2011CA2774333A1 Fusion polypeptides and uses thereof
03/24/2011CA2774235A1 Methods and kits for the identification of animals having a greater potential for desirable characteristics, and for the early identification of fat deposits in bovines
03/24/2011CA2774193A1 Novel method for producing differentiated cells
03/24/2011CA2774166A1 Nucleic acid molecule encoding triterpenoid synthase